Kynam Capital Management, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001907884

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHealth TiltHigh Turnover how tags are computed

Q3 2026 · 34 positions · Total reported value $1.81B · Top-10 concentration 72.3% · Updated 2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

Turnover: 33.3% · 4 new · 6 cut · 2 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -10.0% · vs SPY -12.1% · Prev Value $1.81B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -3.5% · vs SPY -5.7% · Latest Value $1.81B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Kynam Capital Management, LP disclosed 34 equity positions with a combined reported value of $1.81B. The filing implies a focused portfolio: its ten largest positions account for 72.3% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were LEGN ($182.08M), CLDX ($164.19M), SNDX ($153.24M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Kynam Capital Management, LP opened 4 new positions, trimmed 6 and fully exited 2, a turnover rate of 33.3% of positions. The portfolio's overlap with the prior quarter was 83% of names.

The largest new positions opened in Q3 2026 were SRZN ($15.65M), XENE ($10.41M), EVMN ($9.91M).

Of the 2 positions fully exited versus the prior quarter, the largest were INSM ($10.66M), CADL ($996.43K).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • SRZN SURROZEN INC · $15.65M
  • XENE XENON PHARMACEUTICALS INC · $10.41M
  • EVMN EVOMMUNE INC · $9.91M
  • HROW HARROW INC · $3.84M

Fully Exited (vs previous quarter)

  • INSM INSMED INC · prev qtr: $10.66M
  • CADL CANDEL THERAPEUTICS INC · prev qtr: $996.43K

Insider Transactions (Form 4)

Latest Kynam Capital Management, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Kynam Capital Management, LP files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 32 positions worth $1.81B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • SEC registration: 801-126187 (status: Approved), registered 2022-07-22
  • Regulatory AUM (Form ADV): $2.41B as of 2026-04-10
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds

Portfolio Structure

  • 32 positions · $1.81B reported value (Q2 2026)
  • Top 10 holdings = 72.7% of reported value
  • Largest position: CLDX (CELLDEX THERAPEUTICS INC NEW) at 10.9%
  • Average position size: $56.54M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 12 added, 7 reduced, 9 exited
  • 9 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 9.15M $182.08M 10.08%
10.08%
Add
2 5.07M $164.19M 9.09%
9.09%
Reduce
3 8.15M $153.24M 8.48%
8.48%
Add
4 2.61M $148.39M 8.22%
8.22%
Reduce
5 6.15M $126.59M 7.01%
7.01%
Reduce
6 3.79M $121.43M 6.72%
6.72%
Add
7 2.00M $117.76M 6.52%
6.52%
Hold
8 2.43M $98.90M 5.48%
5.48%
Hold
9 3.00M $96.87M 5.36%
5.36%
Add
10 3.93M $96.18M 5.33%
5.33%
Add
11 21.14M $57.50M 3.18%
3.18%
Reduce
12 934.80K $54.80M 3.03%
3.03%
Hold
13 3.00M $50.73M 2.81%
2.81%
Add
14 2.75M $49.66M 2.75%
2.75%
Reduce
15 3.11M $47.80M 2.65%
2.65%
Hold
16 1.38M $41.65M 2.31%
2.31%
Hold
17 1.19M $28.33M 1.57%
1.57%
Hold
18 824.84K $26.16M 1.45%
1.45%
Add
19 1.24M $21.84M 1.21%
1.21%
Hold
20 2.52M $21.01M 1.16%
1.16%
Hold
21 486.25K $15.65M 0.87%
0.87%
New
22 872.56K $14.06M 0.78%
0.78%
Hold
23 280.00K $10.41M 0.58%
0.58%
New
24 1.20M $9.91M 0.55%
0.55%
New
25 2.31M $9.04M 0.50%
0.50%
Reduce
26 6.84M $8.41M 0.47%
0.47%
Hold
27 250.00K $8.07M 0.45%
0.45%
Hold
28 4.31M $7.97M 0.44%
0.44%
Add
29 532.98K $6.93M 0.38%
0.38%
Hold
30 124.66K $3.84M 0.21%
0.21%
New
31 2.50M $3.18M 0.18%
0.18%
Hold
32 1.57M $2.60M 0.14%
0.14%
Hold
33 457.86K $915.71K 0.05%
0.05%
Hold
34 84.40K $50.12K 0.00%
0.00%
Hold

FAQ

What did Kynam Capital Management, LP buy in 2026-Q3?

In its 2026-Q3 13F filing, Kynam Capital Management, LP reported 34 equity positions worth $1.81B in aggregate; its largest disclosed positions were LEGN ($182.08M), CLDX ($164.19M), SNDX ($153.24M).

How large is Kynam Capital Management, LP's portfolio?

Kynam Capital Management, LP reported $1.81B of long equity holdings across 34 positions as of 2026-Q3. Top-10 holdings account for 72.3% of reported value.

What is Kynam Capital Management, LP's investment style?

HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/kynam-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →